No effects on morphological advancement have been observed in embryo-fetal improvement reports with oral administration of methylphenidate to Expecting rats and rabbits through organogenesis at doses approximately 10 and 15 times, respectively, the maximum advised human dose (MRHD) of sixty mg/working day specified to adolescents with a mg/m2 basis